Pfizer France

Actualización oct. 16, 2020
Board
 
N-1
 
N-2 
Family Health
Move' . _tr('hint.contact.drag') . '
 
Communication
Move' . _tr('hint.contact.drag') . '
 
Hospital
Move' . _tr('hint.contact.drag') . '
 
Medical
Move' . _tr('hint.contact.drag') . '
Medical
Move' . _tr('hint.contact.drag') . '
Oncology
Move' . _tr('hint.contact.drag') . '
Inflammation & Immunology
Move' . _tr('hint.contact.drag') . '
Rare Diseases
Move' . _tr('hint.contact.drag') . '
Market Access & Comm
Move' . _tr('hint.contact.drag') . '
 
Vaccines
Move' . _tr('hint.contact.drag') . '
 
Finance
Move' . _tr('hint.contact.drag') . '
 
Legal
Move' . _tr('hint.contact.drag') . '
 
Upjohn
Move' . _tr('hint.contact.drag') . '
 
HR
Move' . _tr('hint.contact.drag') . '
 
Quality & Pharmaceutical
Move' . _tr('hint.contact.drag') . '
Operations
Move' . _tr('hint.contact.drag') . '
 
Mis ejecutivos
Compartir